SCHEMBL7608980

SCHEMBL7608980

CC(=O)NC(C)Cc1ccc(C(=O)CCCC(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACACB O00763 17/20 0.58
PDE4B Q07343 1/20 0.49
SIGMAR1 Q99720 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608981 1.00 ACACB (0.58) ACACBPDE4BSIGMAR1
SCHEMBL11235329 0.92 ACACB (0.60) ACACBSIGMAR1
SCHEMBL11235575 0.84 ACACB (0.58) ACACB
SCHEMBL7610862 0.83 ACACB (0.57) ACACB
SCHEMBL7610856 0.83 ACACB (0.57) ACACB
SCHEMBL11480710 0.82 ACACB (0.62) ACACB
SCHEMBL9684956 0.81 ACACB (0.52) ACACB
SCHEMBL9684948 0.81 ACACB (0.52) ACACB
SCHEMBL9684941 0.81 ACACB (0.52) ACACB
SCHEMBL825426 0.81 ACACB (0.83) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820984-B1 Activated amphetamines ROCHE DIAGNOSTICS GMBH (DE) 2002-03-27 EP disclosed
US-5976812-A Activated amphetamines ROCHE DIAGNOSTICS GMBH (DE) 1999-11-02 US disclosed
EP-0820984-A1 Activated amphetamines Roche Diagnostics GmbH (DE) 1998-01-28 EP disclosed